Related Experiment Videos

Hydrochlorothiazide prevents bone loss in castrated male mice

Broulik1

  • 13rd Department of Internal Medicine, Charles University, Faculty of Medicine, Prague, Czech Republic.

Endocrine Regulations
|March 1, 1997
PubMed

Insights

Castration in male mice causes bone loss, but hydrochlorothiazide treatment prevented these changes. Thiazide administration shows a dose-dependent, beneficial effect on bone mineral content in this osteopenia model.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Pharmacology

Background:

  • Castration in male mice induces osteopenia, a condition characterized by reduced bone mass and density.
  • This model is valuable for investigating interventions targeting bone loss.

Purpose of the Study:

  • To evaluate the effect of hydrochlorothiazide on bone density and mineral content in a mouse model of post-castration osteopenia.
  • To determine if thiazide administration can prevent or mitigate bone loss induced by castration.

Main Methods:

  • Male mice were castrated to induce osteopenia.
  • Castrated mice were treated with varying doses of hydrochlorothiazide.
  • Bone ash weight, bone density, and calcium and phosphate content were measured.

Main Results:

  • Castration led to significant decreases in bone ash weight, density, and mineral content.
  • High-dose hydrochlorothiazide treatment (2 mg/day/mouse) prevented the castration-induced decline in bone density and mineral concentration.
  • The protective effect of thiazides on bone mineral content was found to be dose-dependent.

Conclusions:

  • Long-term administration of hydrochlorothiazide demonstrates a beneficial effect on bone mineral content in male mice with post-castration osteopenia.
  • Thiazide treatment can prevent bone loss associated with castration in this animal model.
  • The study highlights the potential of thiazides as a therapeutic agent for preventing bone loss, with efficacy related to dosage.

Related Concept Videos